Market closedNon-fractional
Assertio/ASRT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Assertio
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Ticker
ASRT
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Lake Forest, United States
Employees
53
Website
www.assertiotx.com
Assertio Metrics
BasicAdvanced
$140M
Market cap
-
P/E ratio
-$4.06
EPS
1.00
Beta
-
Dividend rate
Price and volume
Market cap
$140M
Beta
1
Financial strength
Current ratio
1.866
Quick ratio
1.334
Long term debt to equity
29.72
Total debt to equity
30.312
Interest coverage (TTM)
2.49%
Management effectiveness
Return on assets (TTM)
1.35%
Return on equity (TTM)
-172.90%
Valuation
Price to revenue (TTM)
0.849
Price to book
1.04
Price to tangible book (TTM)
4.86
Price to free cash flow (TTM)
3.604
Growth
Revenue change (TTM)
-12.40%
Earnings per share change (TTM)
-330.38%
3-year revenue growth (CAGR)
7.61%
3-year earnings per share growth (CAGR)
24.19%
What the Analysts think about Assertio
Analyst Ratings
Majority rating from 2 analysts.
Assertio Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$32M
-1.52%
Net income
-$4.5M
-92.15%
Profit margin
-13.88%
-92.03%
Assertio Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.13
-$3.42
-$0.61
-$0.05
-
Expected
$0.14
$0.07
-$0.02
-$0.03
-$0.03
Surprise
-9.88%
-4,706.06%
2,950.00%
66.67%
-
Assertio News
AllArticlesVideos
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
GlobeNewsWire·2 days ago
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewsWire·2 weeks ago
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Assertio stock?
Assertio (ASRT) has a market cap of $140M as of July 27, 2024.
What is the P/E ratio for Assertio stock?
The price to earnings (P/E) ratio for Assertio (ASRT) stock is 0 as of July 27, 2024.
Does Assertio stock pay dividends?
No, Assertio (ASRT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Assertio dividend payment date?
Assertio (ASRT) stock does not pay dividends to its shareholders.
What is the beta indicator for Assertio?
Assertio (ASRT) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Assertio stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.